These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7066489)

  • 1. Purine nucleotide cycle enzymes in dystrophic and normal mouse muscle.
    Fitt PS; Parliament MB
    Biosci Rep; 1982 Mar; 2(3):177-83. PubMed ID: 7066489
    [No Abstract]   [Full Text] [Related]  

  • 2. Enzymes of the purine nucleotide cycle in muscles from normal and dystrophic chickens.
    Clark SW; Peckham RW; Rudolph FB
    Proc Soc Exp Biol Med; 1978 Jul; 158(3):406-9. PubMed ID: 684012
    [No Abstract]   [Full Text] [Related]  

  • 3. A defect of purine nucleotide cycle in the skeletal muscle of hereditary dystrophic mice.
    Sanada H; Yamaguchi M
    Biochem Biophys Res Commun; 1979 Sep; 90(2):453-9. PubMed ID: 508313
    [No Abstract]   [Full Text] [Related]  

  • 4. [The purine nucleotide cycle (author's transl)].
    Makarewicz W
    Postepy Biochem; 1979; 25(2):169-95. PubMed ID: 228258
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of the purine nucleotide cycle in extracts of rat skeletal muscle: effects of energy state and concentrations of cycle intermediates.
    Manfredi JP; Holmes EW
    Arch Biochem Biophys; 1984 Sep; 233(2):515-29. PubMed ID: 6486798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymes of the purine nucleotide cycle in muscle of patients with exercise intolerance.
    Operti MG; Vincent MF; Brucher JM; van den Berghe G
    Muscle Nerve; 1998 Mar; 21(3):401-3. PubMed ID: 9486871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The purine nucleotide profile in mouse, chicken and human dystrophic muscle: an abnormal ratio of inosine plus adenine nucleotides to guanine nucleotides.
    Shuttlewood RJ; Griffiths JR
    Clin Sci (Lond); 1982 Jan; 62(1):113-5. PubMed ID: 7056028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle purine nucleotide cycle enzymes in exercise intolerance.
    Operti MG; Vincent MF; Brucher JM; Van den Berghe G
    Adv Exp Med Biol; 1998; 431():205-9. PubMed ID: 9598060
    [No Abstract]   [Full Text] [Related]  

  • 9. Disruption of the purine nucleotide cycle by inhibition of adenylosuccinate lyase produces skeletal muscle dysfunction.
    Swain JL; Hines JJ; Sabina RL; Harbury OL; Holmes EW
    J Clin Invest; 1984 Oct; 74(4):1422-7. PubMed ID: 6480832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymes of the purine ribonucleotide cycle in rat hepatomas and kidney tumors.
    Jackson RC; Morris HP; Weber G
    Cancer Res; 1977 Sep; 37(9):3057-65. PubMed ID: 195718
    [No Abstract]   [Full Text] [Related]  

  • 11. Occurrence of the purine nucleotide cycle in rat pancreatic islets.
    Marynissen G; Sener A; Malaisse WJ
    Biochem Med Metab Biol; 1992 Oct; 48(2):127-36. PubMed ID: 1419144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study on the regulatory role of fructose-1,6-diphosphate in the formation of AMP in rat skeletal muscle. A mechanism for synchronization of glycolysis and the purine nucleotide cycle.
    Ogawa H; Shiraki H; Nakagawa H
    Biochem Biophys Res Commun; 1976 Jan; 68(2):524-8. PubMed ID: 1252243
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of purine nucleotide cycle to energy production in skeletal muscle.
    Flanagan WF; Holmes EW; Sabina RL; Swain JL
    Am J Physiol; 1986 Nov; 251(5 Pt 1):C795-802. PubMed ID: 3777158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hepatocarcinogens on the adenine purine nucleotide cycle during the initiation phase of carcinogenesis.
    Smith LD; Emerson RL; Nixon LK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2132-8. PubMed ID: 445410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased purine nucleotide cycle activity associated with dietary zinc deficiency.
    Brody MS; Steinberg JR; Svingen BA; Luecke RW
    Biochem Biophys Res Commun; 1977 Sep; 78(1):144-50. PubMed ID: 907666
    [No Abstract]   [Full Text] [Related]  

  • 16. Purine nucleotide cycle, molecular defects and therapy.
    Van den Berghe G; Bontemps F; Vincent MF
    Adv Exp Med Biol; 1991; 309B():281-6. PubMed ID: 1781384
    [No Abstract]   [Full Text] [Related]  

  • 17. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.
    Sabina RL; Swain JL; Olanow CW; Bradley WG; Fishbein WN; DiMauro S; Holmes EW
    J Clin Invest; 1984 Mar; 73(3):720-30. PubMed ID: 6707201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative enzymology of 5'-AMP aminohydrolase from normal and genetically dystrophic chicken muscle.
    Suelter CH; Thompson D; Oakley G; Pearce M; Husic HD; Brody MS
    Biochem Med; 1979 Jun; 21(3):352-65. PubMed ID: 496927
    [No Abstract]   [Full Text] [Related]  

  • 19. Adenylosuccinase in human muscular dystrophy.
    Kar NC; Pearson CM
    Muscle Nerve; 1981; 4(2):174-5. PubMed ID: 7207508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SAMP lyase and AMP deaminase activity in rat parenchymal and kupffer cells in hepatocarcinogenesis.
    Smith LD; Lewis EL; Morrical SW; Butler M
    Int J Biochem; 1984; 16(9):985-90. PubMed ID: 6479436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.